Dr. Bo Yeon Lee is a scientific program manager at National Center for Advancing Translational Sciences (NCATS), National Institute of Health (NIH) where she manages “Tissue Chips for Disease Modeling and Efficacy Testing” program and other special initiatives relevant to the Tissue Chips programs. NCATS, in collaboration with other NIH Institutes and Centers and the Food and Drug Administration, is leading the Tissue Chip for Drug Screening program to develop human tissue chips that accurately model the structure and function of human organs to help predict drug safety in humans more rapidly and effectively.
Prior to joining NCATS, Dr. Lee managed the Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) program, a $50 million/year portfolio in the broad area of neuroscience at National Institute of Mental Health (NIMH), NIH. Dr. Lee worked as a regulatory affairs consultant at PAREXEL in multiple areas of drug development and she has led a multidisciplinary team for bioassay development as a project leader in drug discovery and development at Lundbeck. Dr. Lee has obtained her Ph.D. in toxicology from Texas A&M University where she has also worked as a postdoctoral fellow on a novel therapy for stroke. Dr. Lee holds a degree in veterinary medicine from Chonnam National University in South Korea.